The data on the slide come from a multinational, real-world study estimating the cost of PD, stratified by disease severity.3 The analysis confirmed that the real-world costs of PD were substantial, and those costs increased as PD progressed.1-3 The main factors that drove healthcare costs were the direct cost of hospitalization and medication costs, and indirect costs.3
References:
1.Yang W, Hamilton JL, Kopil C, et al. Current and projected future economic burden of Parkinson’s disease in the U.S. NPJ Parkinsons Dis 2020; 6: 15.
2.Dahodwala N, Li P, Jahnke J, et al. Burden of Parkinson’s disease by severity: health care costs in the U.S. Medicare population. Mov Disord 2021; 36 (1): 133–142.
3.Chaudhuri KR, Azulay JP, Odin P, et al. Economic burden of Parkinson’s disease: a multinational, real-world, cost-of-illness study. Drugs Real World Outcomes 2024; 11 (1): 1–11.
